Overview: Citrate TestIntroduction: The Citrate Test measures citrate in urine to assess kidney stone risk, causing pain or urinary issues. Following 2023 NKF guidelines, it uses spectrophotometry for high sensitivity, aiding in metabolic screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in clinical pathology for patients with suspected kidney stones.
Other Names: Urine Citrate Assay, Kidney Stone Risk Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Citrate testing began in the 1970s with kidney stone research. Spectrophotometry emerged in the 1980s, and by the 2000s, automated analyzers improved accuracy.
Purpose: Assesses kidney stone risk, guides preventive measures, and monitors citrate levels in patients with pain or urinary issues.
Test Parameters: 1. Citrate
Pretest Condition: No fasting required. Collect 24-hour urine at any time. Report symptoms like flank pain or hematuria, and list medications like potassium citrate.
Specimen: 50-100 mL 24-hour urine (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document flank pain, hematuria, or history of kidney stones. Include current medications, especially potassium citrate or diuretics.
Consent: Written consent required, detailing the tests purpose, implications for kidney stone prevention, and potential need for dietary or medical intervention.
Procedural Considerations: Uses spectrophotometry to measure urine citrate levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Incomplete 24-hour collection or contamination may affect results. Improper storage can degrade samples.
Clinical Significance: Low citrate levels indicate increased kidney stone risk, prompting citrate supplementation. Normal levels support ongoing monitoring.
Specialist Consultation: Consult a nephrologist for result interpretation. A urologist referral is advised for recurrent stones.
Additional Supporting Tests: Urine calcium test, renal ultrasound, or 24-hour urine oxalate test to assess kidney stone risk comprehensively.
Test Limitations: Results may vary with diet or hydration status. Clinical correlation with other urinary markers is required.
References: NKF Kidney Stone Guidelines, 2023; American Journal of Kidney Diseases, Curhan GC, 2022.
